[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market Report 2021

August 2016 | 107 pages | ID: G6FB0892F05EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Ventilator Associated Pneumonia (VAP)-Therapeutics

Revenue, means the sales value of Ventilator Associated Pneumonia (VAP)-Therapeutics

This report studies sales (consumption) of Ventilator Associated Pneumonia (VAP)-Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
  • Adenium Biotech
  • Aridis Pharmaceuticals
  • AstraZeneca
  • Merck
  • Cardeas Pharma
  • Dong-A Socio
  • MedImmune
  • Meiji Seika Pharma
  • Nabriva Therapeutics
  • Tetraphase Pharmaceuticals
  • Serendex Pharmaceuticals
  • Savara Pharmaceuticals
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Ventilator Associated Pneumonia (VAP)-Therapeutics in these regions, from 2011 to 2021 (forecast), like
  • North America
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by applications, this report focuses on sales, market share and growth rate of Ventilator Associated Pneumonia (VAP)-Therapeutics in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market Report 2021

1 VENTILATOR ASSOCIATED PNEUMONIA (VAP)-THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Ventilator Associated Pneumonia (VAP)-Therapeutics
1.2 Classification of Ventilator Associated Pneumonia (VAP)-Therapeutics
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Applications of Ventilator Associated Pneumonia (VAP)-Therapeutics
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Ventilator Associated Pneumonia (VAP)-Therapeutics Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Ventilator Associated Pneumonia (VAP)-Therapeutics (2011-2021)
  1.5.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)
  1.5.2 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)
  1.5.3 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)

2 GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP)-THERAPEUTICS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Market Competition by Manufacturers
  2.1.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Share by Manufacturers (2015 and 2016)
2.2 Global Ventilator Associated Pneumonia (VAP)-Therapeutics (Volume and Value) by Type
  2.2.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Type (2011-2021)
  2.2.2 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Market Share by Type (2011-2021)
2.3 Global Ventilator Associated Pneumonia (VAP)-Therapeutics (Volume and Value) by Regions
  2.3.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Regions (2011-2021)
  2.3.2 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Market Share by Regions (2011-2021)
2.4 Global Ventilator Associated Pneumonia (VAP)-Therapeutics (Volume) by Application

3 NORTH AMERICA VENTILATOR ASSOCIATED PNEUMONIA (VAP)-THERAPEUTICS (VOLUME, VALUE AND SALES PRICE

3.1 North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Value (2011-2021)
  3.1.1 North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)
  3.1.2 North America Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
  3.1.3 North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Price Trend (2011-2021)
3.2 North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Manufacturers
3.3 North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Type
3.4 North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Applications

4 CHINA VENTILATOR ASSOCIATED PNEUMONIA (VAP)-THERAPEUTICS (VOLUME, VALUE AND SALES PRICE

4.1 China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Value (2011-2021)
  4.1.1 China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)
  4.1.2 China Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
  4.1.3 China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Price Trend (2011-2021)
4.2 China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Manufacturers
4.3 China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Type
4.4 China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Applications

5 EUROPE VENTILATOR ASSOCIATED PNEUMONIA (VAP)-THERAPEUTICS (VOLUME, VALUE AND SALES PRICE

5.1 Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Value (2011-2021)
  5.1.1 Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)
  5.1.2 Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
  5.1.3 Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Price Trend (2011-2021)
5.2 Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Manufacturers
5.3 Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Type
5.4 Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Applications

6 JAPAN VENTILATOR ASSOCIATED PNEUMONIA (VAP)-THERAPEUTICS (VOLUME, VALUE AND SALES PRICE

6.1 Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Value (2011-2021)
  6.1.1 Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)
  6.1.2 Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
  6.1.3 Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Price Trend (2011-2021)
6.2 Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Manufacturers
6.3 Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Type
6.4 Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Applications

7 SOUTHEAST ASIA VENTILATOR ASSOCIATED PNEUMONIA (VAP)-THERAPEUTICS (VOLUME, VALUE AND SALES PRICE

7.1 Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Value (2011-2021)
  7.1.1 Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)
  7.1.2 Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
  7.1.3 Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Price Trend (2011-2021)
7.2 Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Manufacturers
7.3 Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Type
7.4 Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Applications

8 INDIA VENTILATOR ASSOCIATED PNEUMONIA (VAP)-THERAPEUTICS (VOLUME, VALUE AND SALES PRICE

8.1 India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Value (2011-2021)
  8.1.1 India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)
  8.1.2 India Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
  8.1.3 India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Price Trend (2011-2021)
8.2 India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Manufacturers
8.3 India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Type
8.4 India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Applications

9 GLOBAL VENTILATOR ASSOCIATED PNEUMONIA (VAP)-THERAPEUTICS MANUFACTURERS ANALYSIS

9.1 Adenium Biotech
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Type and Technology
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Company One (2015 and 2016)
9.2 Aridis Pharmaceuticals
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Type and Technology
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Company One (2015 and 2016)
9.3 AstraZeneca
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Type and Technology
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Company One (2015 and 2016)
9.4 Merck
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Type and Technology
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Company One (2015 and 2016)
9.5 Cardeas Pharma
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Type and Technology
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Company One (2015 and 2016)
9.6 Dong-A Socio
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Type and Technology
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Company One (2015 and 2016)
9.7 MedImmune
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Company One (2015 and 2017)
9.8 Meiji Seika Pharma
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Company One (2015 and 2018)
9.9 Nabriva Therapeutics
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Company One (2015 and 2019)
9.10 Tetraphase Pharmaceuticals
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Company One (2015 and 2021)
9.11 Serendex Pharmaceuticals
9.12 Savara Pharmaceuticals

10 VENTILATOR ASSOCIATED PNEUMONIA (VAP)-THERAPEUTICS TECHNOLOGY AND DEVELOPMENT TREND

10.1 Ventilator Associated Pneumonia (VAP)-Therapeutics Technology Analysis
10.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES

Figure Picture of Ventilator Associated Pneumonia (VAP)-Therapeutics
Table Classification of Ventilator Associated Pneumonia (VAP)-Therapeutics
Figure Global Sales Market Share of Ventilator Associated Pneumonia (VAP)-Therapeutics by Type in 2015
Table Applications of Ventilator Associated Pneumonia (VAP)-Therapeutics
Figure Global Sales Market Share of Ventilator Associated Pneumonia (VAP)-Therapeutics by Applications in 2015
Figure North America Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Figure China Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Figure Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Figure Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Figure India Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)
Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)
Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales of Key Manufacturers (2015 and 2016)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Share by Manufacturers
Figure 2016 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Share by Manufacturers
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue by Manufacturers (2015 and 2016)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Share by Manufacturers
Table 2016 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Share by Manufacturers
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Type (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Share by Type (2011-2021)
Figure Sales Market Share of Ventilator Associated Pneumonia (VAP)-Therapeutics by Type (2011-2021)
Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Growth Rate by Type (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Market Share by Type (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Ventilator Associated Pneumonia (VAP)-Therapeutics by Type (2011-2021)
Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Growth Rate by Type (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Regions (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Share by Regions (2011-2021)
Figure Sales Market Share of Ventilator Associated Pneumonia (VAP)-Therapeutics by Regions (2011-2021)
Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Growth Rate by Regions (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Market Share by Regions (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Ventilator Associated Pneumonia (VAP)-Therapeutics by Regions (2011-2021)
Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Growth Rate by Regions (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Application (2011-2021)
Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Share by Application (2011-2021)
Figure Sales Market Share of Ventilator Associated Pneumonia (VAP)-Therapeutics by Application (2011-2021)
Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Growth Rate by Application (2011-2021)
Figure North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)
Figure North America Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Figure North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Price Trend (2011-2021)
Table North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Manufacturers (2015 and 2016)
Table North America Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Manufacturers (2015 and 2016)
Table North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Type (2015 and 2016)
Table North America Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Type (2015 and 2016)
Table North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Applications (2015 and 2016)
Table North America Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Applications (2015 and 2016)
Figure Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)
Figure Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Figure Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Price Trend (2011-2021)
Table Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Manufacturers (2015 and 2016)
Table Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Type (2015 and 2016)
Table Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Type (2015 and 2016)
Table Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Applications (2015 and 2016)
Table Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Applications (2015 and 2016)
Figure China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)
Figure China Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Figure China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Price Trend (2011-2021)
Table China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Manufacturers (2015 and 2016)
Table China Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Manufacturers (2015 and 2016)
Table China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Type (2015 and 2016)
Table China Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Type (2015 and 2016)
Table China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Applications (2015 and 2016)
Table China Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Applications (2015 and 2016)
Figure Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)
Figure Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Figure Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Price Trend (2011-2021)
Table Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Manufacturers (2015 and 2016)
Table Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Type (2015 and 2016)
Table Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Type (2015 and 2016)
Table Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Applications (2015 and 2016)
Table Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Applications (2015 and 2016)
Figure India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)
Figure India Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Figure India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Price Trend (2011-2021)
Table India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Manufacturers (2015 and 2016)
Table India Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Manufacturers (2015 and 2016)
Table India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Type (2015 and 2016)
Table India Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Type (2015 and 2016)
Table India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Applications (2015 and 2016)
Table India Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Applications (2015 and 2016)
Figure Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)
Figure Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Price Trend (2011-2021)
Table Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Manufacturers (2015 and 2016)
Table Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Manufacturers (2015 and 2016)
Table Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Type (2015 and 2016)
Table Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Type (2015 and 2016)
Table Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Applications (2015 and 2016)
Table Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Market Share by Applications (2015 and 2016)
Table Adenium Biotech Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Adenium Biotech (2015 and 2016)
Table Aridis Pharmaceuticals Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Aridis Pharmaceuticals (2015 and 2016)
Table AstraZeneca Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Merck Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Merck (2015 and 2016)
Table Cardeas Pharma Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Cardeas Pharma (2015 and 2016)
Table Dong-A Socio Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Dong-A Socio (2015 and 2016)
Table MedImmune Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of MedImmune (2015 and 2016)
Table Meiji Seika Pharma Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Meiji Seika Pharma (2015 and 2016)
Table Nabriva Therapeutics Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Nabriva Therapeutics (2015 and 2016)
Table Tetraphase Pharmaceuticals Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Tetraphase Pharmaceuticals (2015 and 2016)
Table Serendex Pharmaceuticals Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Serendex Pharmaceuticals (2015 and 2016)
Table Savara Pharmaceuticals Basic Information List
Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Savara Pharmaceuticals (2015 and 2016)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories